Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIFECORE BIOMEDICAL, INC. \DE\ Director's Dealing 2016

Oct 24, 2016

33431_dirs_2016-10-24_4e697161-9e99-4132-90e5-62b6c6305d24.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-10-20

Reporting Person: Midyett Ronald Lane (Chief Operations Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-10-20 Right to Buy Restricted Stock Unit (RSU) $ M 7145 Acquired Common Stock (7145) Direct
2016-10-20 Right to Buy Restricted Stock Unit (RSU) $ M 7145 Acquired Common Stock (7145) Direct

Footnotes

F1: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.

F2: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F3: Restricted Stock Units will vest on the 2nd anniversary of the grant date and will be automatically settled in shares of common stock.